2m 2m 2m 2m 2m 2m 2m
Entia Bioscience (ERGO)
OTC
$0.0008+$0.0006 (+300.00%)
Price as of Aug 20, 2026- $6,732.00Market Cap
- 700.00%1-Year Change
- BiotechnologyIndustry
Entia Bioscience (ERGO)
$0.0008+$0.0006 (+300.00%)
ERGO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.00 | ||
Change | +$0.0006 (+300.00%) | ||
Open | $0.00 | ||
High | $0.00 | ||
Low | $0.00 | ||
Previous Close | $0.00 | ||
Volume | 2,000 | ||
30-Day Average Volume | 4,825 | ||
1-Week Change | 300.00% | ||
1-Month Change | 300.00% | ||
1-Year Change | 700.00% | ||
3-Year Change | 300.00% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 33.7M | ||
Total Assets | $439,141.00 | ||
Market Cap | $6,732.00 | ||
Enterprise Value | $976,682.00 | ||
Period: QTR TTM FY | |||
Revenue | $45,986.00 | ||
Net Income | -$432,783.00 | ||
Free Cash Flow | -$439,956.00 | ||
EBIT | -$389,187.00 | ||
EBITDA | -$385,694.00 | ||
Net Working Capital | -$1.9M | ||
EPS | -$0.02 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | 21 | ||
P/B | -0 | ||
P/E | -0 | ||
PEG | 0 | ||
Price/Free Cash Flow | -0 | ||
Price/Operating Cash Flow | -0 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 02/15/2012 | ||